THE HUB

Developing an Array of Diverse Vaccine Platforms

April. 10, 2024 (Novavax) --  The past few years have seen tremendous advances in the field of vaccinology, including developments in vaccine technology. These advances mean more options for providers, patients and policy makers — and more opportunities for pharma to leverage the latest technologies to develop novel protein-based vaccines.

Bay Area health officials issue measles warning

March. 29, 2024 (NBC/Bay Area) -- Measles is once again showing up in America. Outbreaks of the virus once believed to be eradicated in the U.S. have now been reported in several states that includes northern California. NBC Bay Area’s Raj Mathai spoke to UCSF’s Dr. Peter Chin-Hong for some insight.

Vaccines to Watch in 2024

March. 19, 2024 (Drug Topics Journal) -- Public attitudes toward vaccination have become increasingly complex in recent years. Factors such as vaccine fatigue and misinformation—which began circulating during the COVID-19 pandemic and has persisted—have eroded trust in vaccination, making some individuals hesitant to roll up their sleeves. Some who had previously relied on vaccine regimens began to question their value, increasing skepticism and causing a dip in vaccine uptake.

Latest COVID Vaccine Shields Against Current Dominant Strain

February. 2, 2024 ( USN/HealthDay News) -- In some good news for those folks who rolled up their sleeves for the latest COVID vaccine last fall, new government research shows the updated shots halve the chances of getting a symptomatic infection.

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

January 18, 2024 ( CBS News) --Rates of routine childhood vaccination hit a 10-year low in 2023. That, according to the Centers for Disease Control and Prevention, puts about 250,000 kindergartners at risk for measles, which often leads to hospitalization and can cause death. In recent weeks, an infant and two young children have been hospitalized amid an ongoing measles outbreak in Philadelphia that spread to a day care center.

The New Vaccines to Get in 2024

January 11, 2024TIME Magazine reports: The U.S. Centers for Disease Control and Prevention (CDC) is recommending new vaccines for adults and kids in 2024, according to its latest annual guidelines finalized Jan. 11. The CDC’s Advisory Committee on Immunization Practices (ACIP), a collection of medical and public-health experts who regularly review evidence and research about vaccines, compiled the new guidelines.

What To Know About the Variant JN.1

January 8, 2024 (Scientific American)  A new variant of the COVID-causing virus SARS-CoV-2 is behind the latest surge in infections this winter, but it doesn't appear to cause more severe disease

A New Covid Variant Is Causing Cases to Rise. Here’s How to Protect Yourself

Alex Fulton of Healthy Women writes about the steps you can take to reduce the risk of getting seriously sick from Covid

Novavax presentations during WVC at the World Vaccine Congress 2024 between 10am and 4pm. Don’t miss these very important topics

April. 3, 2024 (Novavax) --  Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will showcase continued progress on data from its updated COVID-19 vaccine (NVX-CoV2601) and provide an overview of its influenza and COVID-19-Influenza Combination (CIC) vaccine candidates at the World Vaccine Congress 2024 (WVC) in Washington, DC, April 2 to 4, 2024.

New data from Novavax's ongoing research on its updated XBB.1.5 COVID-19 vaccine in participants who previously received an mRNA vaccine showed robust neutralizing antibody titers for the XBB.1.5 subvariant as well as for the currently circulating JN.1 subvariant. Data also showed that the vaccine's safety and reactogenicity profile was consistent with its prototype vaccine (NVX-CoV2373).

Moderna says new Covid vaccine showed stronger immune response than current shot in study

March. 26, 2024 (CNBC/Health and Science) -- Moderna said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot on the market in a late-stage trial. The biotech company’s new “next-generation” shot offers the potential of a longer shelf life and is one component of its combination vaccine targeting Covid and the flu.

Measles Outbreaks Highlight Just How Vital Vaccinations Are Key

February. 14, 2024 (USN/HealthDay News) -- As immunization rates fall and skepticism grows, family physicians play a fundamental role in dispelling myths around vaccines.

No cervical cancer cases detected in vaccinated women following HPV immunisation

January. 22, 2024 (Public Health Scotland) -- An exciting new study from Public Health Scotland (PHS), in collaboration with the Universities of Strathclyde and Edinburgh, shows that no cervical cancer cases have been detected in fully vaccinated women following the human papillomavirus (HPV) immunisation at age 12-13 since the programme started in Scotland in 2008.

Statement – COVID-19 vaccines saved at least 1.4 million lives in the European Region

January 16, 2024 ( World Health Organization) -- Statement by Dr Hans Henri P. Kluge, WHO Regional Director for Europe

​FDA’s Califf calls for more plain-language scientific evidence to dilute vaccine misinformation

January 9, 2024 Fierce Pharma reports: FDA commissioner Robert Califf has urged the clinical and biomedical community to step up efforts to counter vaccine misinformation with “accurate plain-language information” about the benefits and risks of vaccination.

Real-world analysis: COVID-19 vaccine is strongly effective for children and adolescents during delta and omicron

January 8, 2024 (Penn Medicine News) Health record analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated, and cardiac conditions did not increase

Understanding the Different Types of Covid-19 Vaccines

The article by Alex Fulton of Healthy Women, talks about the two types of Covid-19 vaccines and understanding your options.